APA (7th ed.) Citation

YH, P., L, J., CY, L., CH, L., L, L., HY, C., . . . Y, H. (2018). Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway. Dove Medical Press.

Chicago Style (17th ed.) Citation

YH, Pan, Jiao L, Lin CY, Lu CH, Li L, Chen HY, Wang YB, and He Y. Combined Treatment with Metformin and Gefitinib Overcomes Primary Resistance to EGFR-TKIs with EGFR Mutation via Targeting IGF-1R Signaling Pathway. Dove Medical Press, 2018.

MLA (8th ed.) Citation

YH, Pan, et al. Combined Treatment with Metformin and Gefitinib Overcomes Primary Resistance to EGFR-TKIs with EGFR Mutation via Targeting IGF-1R Signaling Pathway. Dove Medical Press, 2018.